Hide filtersShow filters × Close Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Medincell, an innovative pharmaceutical company developing a portfolio of long-acting injectable products, on a EUR 42.9m Follow-on Offering Bryan, Garnier & Co acts as Joint Bookrunner on Faron Pharmaceuticals’ EUR 12 million Follow-On Offering Bryan, Garnier & Co acts as Sole Financial Advisor on Median Technologies’ EUR 10 million Bridge Financing Bryan, Garnier & Co acts as Sole Financial Advisor, Joint Global Coordinator & Joint Bookrunner on Exact Therapeutics’ NOK 145m Follow-On Offering anchored for USD 7m by GE Healthcare Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on ONWARD Medical’s EUR 50m Follow-On Offering, anchored for EUR 22.5m by a Cornerstone Investment from Ottobock Bryan, Garnier & Co acts as Sole Global Coordinator & Joint Bookrunner on Egetis Therapeutics’ SEK 300 million Follow-On Offering Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Valneva’s EUR 61.2m Follow-On Offering Bryan, Garnier & Co acts as Sole Global Coordinator & Sole Bookrunner on Nicox’s Euronext Paris EUR 3.3m Rights Issue Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Cinclus Pharma’s SEK 715m Nasdaq Stockholm IPO Bryan, Garnier & Co acts as Sole Financial Advisor to German medical device CRO/CDMO seleon GmbH Bryan, Garnier & Co acts as Sole Global Coordinator & Joint Bookrunner on ONWARD Medical’s EUR 20 million Follow-On Offering Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner on GeNeuro’s EUR 5m Follow-on Offering
